Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Karnon

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Applied Health Economics and Health Policy|April 7, 2020
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 PandemicJonathan Karnon
Pharmacoeconomics|October 21, 2017
Heath State Utility Values for Cost-Effectiveness ModelsJonathan Karnon
Pharmacoeconomics|May 27, 2016
Model Validation: Has it's Time Come?Jonathan Karnon
Health Economics|September 26, 2003
Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulationJonathan Karnon
Pharmacoeconomics|March 8, 2006
Aromatase inhibitors in breast cancer: a review of cost considerations and cost effectivenessJonathan Karnon
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of letrozole in the treatment of advanced breast cancerJonathan Karnon
Applied Health Economics and Health Policy|April 17, 2020
The Case for a Temporary COVID-19 Income Tax Levy Now, During the CrisisJonathan Karnon
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Cost-effectiveness of letrozole, anastrozole and exemestane for early adjuvant breast cancerJonathan Karnon
Journal of Health Services Research & Policy|January 16, 2010
Medication errors--what is the best way to reduce their impact on patients' health?Jonathan Karnon
Health Policy (Amsterdam, Netherlands)|July 6, 2002
Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysisJonathan Karnon
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Applied Health Economics and Health Policy|April 7, 2020
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 PandemicJonathan Karnon
Pharmacoeconomics|October 21, 2017
Heath State Utility Values for Cost-Effectiveness ModelsJonathan Karnon
Pharmacoeconomics|May 27, 2016
Model Validation: Has it's Time Come?Jonathan Karnon
Health Economics|September 26, 2003
Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulationJonathan Karnon
Pharmacoeconomics|March 8, 2006
Aromatase inhibitors in breast cancer: a review of cost considerations and cost effectivenessJonathan Karnon
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of letrozole in the treatment of advanced breast cancerJonathan Karnon
Applied Health Economics and Health Policy|April 17, 2020
The Case for a Temporary COVID-19 Income Tax Levy Now, During the CrisisJonathan Karnon
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Cost-effectiveness of letrozole, anastrozole and exemestane for early adjuvant breast cancerJonathan Karnon
Journal of Health Services Research & Policy|January 16, 2010
Medication errors--what is the best way to reduce their impact on patients' health?Jonathan Karnon
Health Policy (Amsterdam, Netherlands)|July 6, 2002
Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysisJonathan Karnon
Pageof 22